CONMED Corporation (CNMD)
Profitability ratios
Return on sales
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 54.33% | 53.56% | 53.51% | 53.76% | 54.64% | 55.70% | 56.21% | 56.41% | 56.21% | 55.35% | 55.09% | 53.29% | 53.37% | 53.37% | 53.22% | 54.95% | 54.94% | 55.26% | 55.02% | 54.91% |
| Operating profit margin | 9.69% | 5.93% | 5.55% | 5.49% | 6.70% | 10.14% | 10.63% | 10.98% | 10.86% | 9.82% | 10.21% | 6.01% | 5.33% | 5.62% | 4.68% | 8.48% | 8.28% | 8.26% | 7.50% | 7.50% |
| Pretax margin | 6.49% | 2.53% | 2.20% | -7.82% | -6.78% | -2.87% | -2.78% | 7.92% | 7.23% | 5.76% | 5.81% | 0.89% | 0.19% | 0.61% | -0.29% | 3.86% | 3.27% | 3.68% | 3.45% | 4.14% |
| Net profit margin | 5.18% | 4.96% | 7.75% | -8.53% | -7.71% | -7.74% | -10.93% | 6.63% | 6.19% | 6.29% | 5.53% | 1.53% | 1.10% | 0.04% | 0.05% | 3.53% | 3.00% | 3.15% | 3.13% | 3.56% |
Conmed Corp.'s profitability ratios have shown fluctuations over the past eight quarters.
1. Gross Profit Margin:
- The gross profit margin has ranged between 53.51% to 54.64% in the past year, indicating relatively stable profitability in their core operations of manufacturing and selling goods.
2. Operating Profit Margin:
- The operating profit margin ranged between 5.49% to 10.99%. There was a noticeable decline in Q4 2023 compared to the previous quarters, possibly due to increased operating expenses or lower sales revenue.
3. Pretax Margin:
- The pretax margin has shown significant volatility, ranging from -7.82% to 7.92%. The negative margins in Q1 2023 and Q4 2022 could be attributed to one-time charges or financial difficulties during those periods.
4. Net Profit Margin:
- The net profit margin fluctuated between -10.93% to 7.75%. Negative margins in Q1 and Q4 2022 and Q1 2023 suggest challenges in controlling costs and generating sufficient profits after accounting for all expenses.
Overall, Conmed Corp. should focus on improving cost efficiency, managing operating expenses, and enhancing revenue generation to stabilize and improve its profitability ratios in the future.
Return on investment
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | 5.24% | 2.98% | 2.72% | 2.60% | 3.05% | 4.73% | 5.35% | 6.28% | 6.21% | 5.54% | 5.67% | 3.03% | 2.63% | 2.82% | 2.36% | 4.61% | 4.46% | 4.38% | 3.84% | 3.73% |
| Return on assets (ROA) | 2.80% | 2.49% | 3.80% | -4.04% | -3.51% | -3.61% | -5.50% | 3.79% | 3.54% | 3.55% | 3.07% | 0.77% | 0.54% | 0.02% | 0.02% | 1.91% | 1.61% | 1.67% | 1.60% | 1.77% |
| Return on total capital | 14.46% | 8.71% | 8.11% | -6.87% | -5.63% | -0.51% | -0.34% | 14.05% | 13.83% | 12.70% | 13.39% | 7.26% | 6.44% | 7.11% | 5.92% | 11.34% | 10.41% | 4.87% | 4.23% | 4.11% |
| Return on equity (ROE) | 7.73% | 7.28% | 11.32% | -12.46% | -10.81% | -11.55% | -16.93% | 8.57% | 7.96% | 8.24% | 7.27% | 1.85% | 1.34% | 0.05% | 0.06% | 4.78% | 4.03% | 4.19% | 4.04% | 4.50% |
Conmed Corp.'s profitability ratios show a mixed performance over the past eight quarters.
1. Operating return on assets (Operating ROA) has been relatively stable with a slight increase from 2.60% in Q1 2023 to 5.24% in Q4 2023. This indicates that the company has been able to generate more operating income per dollar of assets.
2. Return on assets (ROA) shows fluctuating results, ranging from a low of -4.04% in Q1 2023 to a high of 3.80% in Q2 2023. The negative figures in Q1 2023 and Q4 2022 suggest the company may have incurred losses during those periods.
3. Return on total capital is also showing variability, with the highest figure of 7.45% in Q1 2022 and the lowest figure of 3.32% in Q4 2023. This ratio measures the return generated from all sources of capital employed by the company.
4. Return on equity (ROE) displays similar fluctuations, with the highest value of 11.32% in Q2 2023 and the lowest value of -16.93% in Q2 2022. The negative figures in some quarters indicate that Conmed Corp. may have struggled to generate a profit for its shareholders during those periods.
Overall, the company's profitability performance is not consistent, with some quarters showing strong profitability metrics while others show weaknesses. It is important for Conmed Corp. to identify the factors contributing to the fluctuations in profitability and take appropriate measures to improve its overall financial performance.